Does INFLIXIMAB Cause Pulmonary toxicity? 96 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 96 reports of Pulmonary toxicity have been filed in association with INFLIXIMAB (Renflexis). This represents 0.1% of all adverse event reports for INFLIXIMAB.
96
Reports of Pulmonary toxicity with INFLIXIMAB
0.1%
of all INFLIXIMAB reports
18
Deaths
40
Hospitalizations
How Dangerous Is Pulmonary toxicity From INFLIXIMAB?
Of the 96 reports, 18 (18.8%) resulted in death, 40 (41.7%) required hospitalization, and 19 (19.8%) were considered life-threatening.
Is Pulmonary toxicity Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for INFLIXIMAB. However, 96 reports have been filed with the FAERS database.
What Other Side Effects Does INFLIXIMAB Cause?
Off label use (34,801)
Drug ineffective (33,738)
Condition aggravated (16,616)
Rheumatoid arthritis (16,251)
Pain (15,061)
Fatigue (13,473)
Arthralgia (13,441)
Infusion related reaction (12,946)
Product use issue (12,752)
Drug intolerance (11,173)
What Other Drugs Cause Pulmonary toxicity?
AMIODARONE (886)
METHOTREXATE (811)
HYDROXYCHLOROQUINE (411)
RITUXIMAB (404)
TOCILIZUMAB (395)
LEFLUNOMIDE (364)
ABATACEPT (359)
ADALIMUMAB (326)
PEMBROLIZUMAB (318)
ETANERCEPT (291)
Which INFLIXIMAB Alternatives Have Lower Pulmonary toxicity Risk?
INFLIXIMAB vs INFLIXIMAB-ABDA
INFLIXIMAB vs INFLIXIMAB-AXXQ
INFLIXIMAB vs INFLIXIMAB-DYYB
INFLIXIMAB vs INFLIXIMAB-QBTX
INFLIXIMAB vs INFLIXIMAB, RECOMBINANT